| Completed | 2 | 32 | US | MAP0010 low dose, MAP0010 high dose, Budesonide inhalation suspension 0.25mg, Pulmicort Respules®, Budesonide inhalation suspension 0.5mg | Allergan, MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan | Asthma | 01/08 | 03/08 | | |
NCT00995904: Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma |
|
|
| Completed | 2 | 25 | US | 84ug MAP0020, 42ug MAP0020, 21ug MAP0020 | Allergan, MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan | Asthma | 11/09 | 11/09 | | |